Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial
- PMID: 32217952
- DOI: 10.1097/AOG.0000000000003786
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial
Comment in
-
In Reply.Obstet Gynecol. 2020 Apr;135(4):970-971. doi: 10.1097/AOG.0000000000003782. Obstet Gynecol. 2020. PMID: 32217954 No abstract available.
Comment on
-
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.Obstet Gynecol. 2020 Jan;135(1):158-165. doi: 10.1097/AOG.0000000000003620. Obstet Gynecol. 2020. PMID: 31809439 Clinical Trial.
References
-
- Creinin MD, Hou MY, Dalton L, Steward R, Chen MJ. Mifepristone antagonization with progesterone to prevent medical abortion: a randomized controlled trial. Obstet Gynecol 2020;135:158–65.
-
- Grossman D, White K, Harris L, Reeves M, Blumenthal PD, Winikoff B, et al. Continuing pregnancy after mifepristone and “reversal” of first trimester medical abortion: a systematic review. Contraception 2015;92:206–11.
-
- Delgado G, Davenport ML. Progesterone use to reverse the effects of mifepristone. Ann Pharmacother 2012;46:e36.
-
- Garrett D, Turner JV. Progesterone for preventing pregnancy termination after initiation of medical abortion with mifepristone. Eur J Contracept Reprod Health Care 2017;22:472–5.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
